|
Name |
Cytochalasin D
|
Molecular Formula | C30H37NO6 | |
IUPAC Name* |
[(1R,5R)-16-benzyl-5,12-dihydroxy-5,7,14-trimethyl-13-methylidene-6,18-dioxo-17-azatricyclo[9.7.0.01,15]octadeca-3,9-dien-2-yl] acetate
|
|
SMILES |
CC1CC=CC2C(C(=C)C(C3[C@@]2(C(C=C[C@@](C1=O)(C)O)OC(=O)C)C(=O)NC3CC4=CC=CC=C4)C)O
|
|
InChI |
InChI=1S/C30H37NO6/c1-17-10-9-13-22-26(33)19(3)18(2)25-23(16-21-11-7-6-8-12-21)31-28(35)30(22,25)24(37-20(4)32)14-15-29(5,36)27(17)34/h6-9,11-15,17-18,22-26,33,36H,3,10,16H2,1-2,4-5H3,(H,31,35)/t17?,18?,22?,23?,24?,25?,26?,29-,30-/m1/s1
|
|
InChIKey |
SDZRWUKZFQQKKV-BPYILLIUSA-N
|
|
Synonyms |
cytochalasin D; Zygosporin A;NSC 209835; 22144-77-0
|
|
CAS | 22144-77-0 | |
PubChem CID | 146158182 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 507.6 | ALogp: | 2.7 |
HBD: | 3 | HBA: | 6 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 113.0 | Aromatic Rings: | 4 |
Heavy Atoms: | 37 | QED Weighted: | 0.425 |
Caco-2 Permeability: | -4.942 | MDCK Permeability: | 0.00003880 |
Pgp-inhibitor: | 0.035 | Pgp-substrate: | 0.031 |
Human Intestinal Absorption (HIA): | 0.185 | 20% Bioavailability (F20%): | 0.009 |
30% Bioavailability (F30%): | 0.002 |
Blood-Brain-Barrier Penetration (BBB): | 0.651 | Plasma Protein Binding (PPB): | 85.21% |
Volume Distribution (VD): | 1.683 | Fu: | 17.70% |
CYP1A2-inhibitor: | 0.016 | CYP1A2-substrate: | 0.094 |
CYP2C19-inhibitor: | 0.071 | CYP2C19-substrate: | 0.459 |
CYP2C9-inhibitor: | 0.048 | CYP2C9-substrate: | 0.098 |
CYP2D6-inhibitor: | 0.01 | CYP2D6-substrate: | 0.094 |
CYP3A4-inhibitor: | 0.925 | CYP3A4-substrate: | 0.489 |
Clearance (CL): | 2.984 | Half-life (T1/2): | 0.11 |
hERG Blockers: | 0.006 | Human Hepatotoxicity (H-HT): | 0.072 |
Drug-inuced Liver Injury (DILI): | 0.874 | AMES Toxicity: | 0.012 |
Rat Oral Acute Toxicity: | 0.731 | Maximum Recommended Daily Dose: | 0.409 |
Skin Sensitization: | 0.016 | Carcinogencity: | 0.155 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.009 |
Respiratory Toxicity: | 0.524 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004468 | 0.818 | D06CWH | 0.274 | ||||
ENC003300 | 0.802 | D0V3ZA | 0.273 | ||||
ENC004463 | 0.772 | D0SP3D | 0.272 | ||||
ENC004444 | 0.770 | D01TSI | 0.266 | ||||
ENC005442 | 0.765 | D09NNH | 0.265 | ||||
ENC002202 | 0.765 | D0W7RJ | 0.261 | ||||
ENC004341 | 0.752 | D0R1BD | 0.252 | ||||
ENC006059 | 0.752 | D0A5LH | 0.247 | ||||
ENC005506 | 0.752 | D0TB8C | 0.245 | ||||
ENC005175 | 0.752 | D0D7KC | 0.245 |